FND symptoms | Primary outcome measures |
Seizures (k=15) | Core symptoms
|
Life impact
| |
Other
| |
Movement disorder (k=7) | Core symptoms
|
| |
Other
| |
Paralysis/weakness (k=4) | Core symptoms
|
| |
Life impact
| |
Mixed motor symptoms (k=4) | Core symptoms
|
Life impact
| |
Other
| |
Other mixed symptoms (k=10) | Core symptoms
|
| |
| |
| |
Life impact
| |
| |
Other
|
References S1-S23 are available in Supplementary File 7
CGI-I, Clinical Global Impression–Improvement; FMD, functional movement disorder; FND, functional neurological disorder; HCU, healthcare use; k, number of studies; MRS, Modified Rankin Scale; PMDRS, Psychogenic Movement Disorder Rating Scale; QoLIE-31, Quality of Life In Epilepsy-31; SDQ-20, Somatoform Dissociation Questionnaire-20 item; SF-12, 12-Item Short Form Health Survey; SF-36, 36-Item Short Form Health Survey; WSAS, Work and Social Adjustment Scale.